FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib
Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer
Increased global efficiency, as well as decreased characteristic path length and altered nodal centralities, seen on functional MRI
FDA Announces Plan to Phase Out Some Animal Testing
New strategy aims to enhance drug safety, expedite evaluation process, and decrease animal experimentation
CDC Urges Extra Measles Shot for Some U.S. Travelers Amid Outbreak
FDA Reverses Office Order, Lets Staff Work From Home
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022
Low LDL-C Levels Linked to Reduced Risk for Dementia
Statin use linked to reduction in risks for all-cause dementia and Alzheimer disease-related dementia
Racial Disparities Seen in Unintentional Overdose Mortality
Black men and Black women have pronounced and increasing burden of mortality compared with Whites
Medical Cannabis Improves Health-Related Quality of Life With Chronic Conditions
Additionally, specific symptom improvement seen
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
Tolebrutinib treatment associated with 31 percent risk reduction in six-month confirmed disability progression versus placebo
